INTRODUCTION
Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common hereditary small vessel disease that is characterized by recurrent subcortical ischemic strokes and ultimately vascular dementia (1 -5) . The pathological hallmark of the disorder comprises a non-amyloid and systemic angiopathy affecting mainly small and medium-size arteries (6, 7) . These vascular lesions are characterized by degeneration and loss of vascular smooth muscle cells (VSMCs), as well as the abnormal accumulation of granular osmiophilic material (GOM) that is also associated with the extracellular domain of Notch3 (8) . CADASIL is caused by missense mutations and small deletions in the NOTCH3 gene located on chromosome 19p13.1 -13.2 (9, 10) . More than 170 different mutations have been found in families of many ethnic origins (11) . Because Notch3 is robustly expressed in VSMCs of the vessel wall (12) , VSMCs are the primary target of the pathogenic process in CADASIL.
The NOTCH genes, four of which are known to exist, encode highly conserved transmembrane (TM) receptors of about 300 kDa that are involved in cell fate specification during embryonic development (13) . The basic structure of the Notch receptor is common to all Notch proteins: the large extracellular domain is composed of a stretch of tandem epidermal growth factor (EGF)-like repeats involved in ligand binding, and the intracellular domain includes Ankyrin/Cdc10 repeats flanked by functional nuclear localization signal sequences. During maturation and activation, Notch receptors undergo at least three distinct proteolytic cleavages. Following ligand interaction, the third (S3) cleavage occurs within the TM domain close to the cytoplasmic border by g-secretase (14) , which releases the intracellular domain from the cell membrane, allowing it to translocate to the nucleus and modify the transcription of target genes (15) .
Thus far, the mechanisms underlying the pathological alterations in CADASIL remain unclear. CADASIL-causing mutations result in an odd number of cysteine residues in the EGF-like repeats (10) . Therefore, the formation of abnormal disulfide bridges has been thought to affect receptor trafficking, processing, specificity for ligand binding and/or signal transduction (10) . It remains controversial, however, whether CADASIL mutations affect receptor trafficking and signal transduction. Recent studies have suggested that mutations located in the ligand-binding site can impair signal transduction activity, whereas neither Notch3 processing nor signaling was significantly affected by other mutations outside of the ligand-binding site (16 -19) . On the other hand, transgenic mice expressing mutant human Notch3 (R90C) exhibited early arterial defects in normal appearing VSMC anchorage onto the adjacent extracellular matrix and cells as well as the VSMC cytoskeleton (20) . These changes were followed by the appearance of GOM deposits, suggesting that cell adhesion or the cell -matrix interaction may be affected by mutations in Notch3 and that GOM deposits are not directly involved in the early stages of VSMC abnormalities. Proteomic studies using cultivated VSMCs from a CADASIL patient also revealed differences in the expression levels of proteins involved in protein degradation and folding, indicating that mutant Notch3 causes endoplasmic reticulum (ER) stress and activates the unfolded protein response (UPR) (21) . Therefore, it is plausible that mutant Notch3 instigates cytotoxic effects and induces misfolding or aggregation of proteins.
To investigate the toxic effect of mutant Notch3 in culture cells, we established Notch3-inducible human embryonic kidney (HEK) 293 cell lines using the tetracycline (Tet)-on regulatory system. Here, we report that mutants of Notch3 are more prone to form aggregates, which accumulate in the ER, and more resistant to ER-associated degradation (ERAD) than wild-type Notch3. In addition, we conclude that cells expressing mutant Notch3 exhibit impaired proliferation and increased sensitivity to proteasome inhibition resulting in cell death.
RESULTS

Preparation of stable cell lines
To study the role of mutant Notch3 in CADASIL pathogenesis, we first generated cultured human aortic smooth muscle cells (Clonetics AoSMC, Lonza) expressing either wild-type or mutant [arginine 133 to cysteine (p.R133C) or cysteine 185 to arginine (p.C185R)] human Notch3. The expression of Notch3 in VSMC, however, caused excessive cell death as early as 2 days after transfection. Therefore, we established stable HEK293 cell lines in which the expression of Notch3 was inducible using the tetracycline (Tet)-on regulatory system (T-Rex system; Invitrogen). Several cell lines were obtained and at least three cell lines for each construct were selected for subsequent experimentation on the basis of equivalent expression of Notch3 (Fig. 1) . Overexpression of either wild-type Notch3 or mutant Notch3 caused a pronounced increase in the expression of the ER-resident protein-folding chaperones GRP78/BiP and ERp72 (Fig. 1) . These cell lines were morphologically indistinguishable by light microscopy and exhibited similar doubling rates.
Subcellular localization of Notch3
We determined whether inducible expression of Notch3 altered the intracellular localization of mutant Notch3. The expression of either wild-type Notch3 or mutant Notch3 was induced for 24 h by tetracycline, and cells were then immunostained with Notch3 antibodies and analyzed by light microscopy. As shown in Figure 2A , mutant Notch3 tended to form dot-like aggregates in the perinuclear region of the cytoplasm, and intense immunoreactivity was detected, while only a few cells expressing with wild-type Notch3 contained the aggregates. Quantification of Notch3 immunostaining of stable cell lines revealed that nearly 50% of the mutant Notch3-expressing cells contained the intracellular aggregates. In contrast, wild-type Notch3-expressing cells containing the aggregates accounted for 15% of the total cells (Fig. 2B) .
In further analysis, we determined the precise intracellular localization of Notch3 aggregates by doubleimmunocytochemistry using two different ER markers (GRP78/BiP and calnexin) and a Golgi complex marker (58 K protein). In cells expressing either wild-type or mutant Notch3, most of the aggregates were colocalized with GRP78/BiP and calnexin (Fig. 3) . Golgi 58 K immunoreactivity, however, was not apparent in the aggregates (Supplementary Material, Fig. S1 ), indicating that the Golgi complex was not involved. These observations indicated that mutant Notch3 was prone to aggregation and accumulated in the ER. 
Clearance of wild-type and mutant Notch3
The results of the immunostaining described above demonstrated that mutant Notch3 formed aggregates that are retained in the ER. Many studies have reported that mutations in proteins often cause structural alterations and result in misfolded proteins that are sequestered by ER chaperones for refolding and trafficking, before ultimately being eliminated by the ERAD system (22 -28) . Therefore, we determined the degradation rates of wild-type Notch3 and mutant Notch3 using pulse-chase experiments. Stable cells were treated with tetracycline for 24 h, radiolabeled for 2 h and then chased for 1 -2 days in medium containing unlabeled methionine and cysteine. The labeled proteins were immunoprecipitated using an anti-Notch3 antibody. As shown in Figure 4 , labeled wild-type Notch3 rapidly disappeared within 2 days and its half-life was determined to be 0.7 days. In contrast, .70% of labeled mutant Notch3 proteins were still detectable after 2 days of chase (Fig. 4B) ; the half-lives of the mutants were estimated to be 9 days for p.R133C and 6 days for p.C185R from the slopes of the relative intensity curves. This slower degradation of mutant Notch3 was assayed by immunostaining stable cells (Fig. 5) . The cells were treated with tetracycline for 24 h and then cultured in medium without tetracycline for 2 days. As expected, dot-like aggregates in the immunopositive cells of wild-type Notch3 quickly disappeared, whereas mutant aggregates did not show any discernible reduction up to 2 days. Quantitative analysis revealed that cell numbers with mutant aggregates did not appear to change for 2 days after turning off expression of the mutant Notch3. These results were confirmed by quantitative western blot analysis of stable cell lines (Supplementary Material, Fig. S2 ), although the amounts of mutant Notch3 (p.R133C) increased slightly at 1 day. It was also noted that wild-type Notch3 was almost entirely degraded within 2 days after arresting its expression. Thus, the aggregates of mutant Notch3 were highly resistant to degradation by the ERAD system.
Mutant Notch3 binds to ER chaperones
It has been reported that misfolded or aggregated proteins that are retained in the ER are associated with ER chaperones (22 -27) . We examined whether mutant Notch3 interacts with certain ER chaperones. Cell lysates were subjected to immunoprecipitation with an anti-Notch3 antibody, and the immunoprecipitated complexes were analyzed by western blotting. As shown in Figure 6 , the chaperone calnexin co-immunoprecipitated with mutant Notch3 but not with wildtype Notch3, indicating that mutant Notch3 interacted exclusively with calnexin. On the other hand, GRP78/BiP co-immunoprecipitated with both the wild-type and mutant Notch3, although the amount of GRP78/BiP was higher in the mutant Notch3 immunoprecipitated samples than in the wild-type sample. The other chaperones, ERp72 and PDI, were not detected in immunoprecipitated samples of wild-type or mutant Notch3. These findings suggest that aggregation of mutant Notch3 may lead to prolonged association with calnexin, leading to retention of the aggregates in the ER.
Expression of mutant Notch3 inhibits cell proliferation
We further determined whether expression of mutant Notch3 affects cell viability. Figure 7A shows the typical growth profile as assessed by cell counting over a variable period lasting from 1 to 5 days. Expression of mutant Notch3 in tetracycline-treated cells decreased the cell number compared with that in untreated cells, whereas expression of wild-type Notch3 had relatively little overall effect on cell growth. The growth rates of cells expressing mutant Notch3 were not improved after turning off the expression of mutant Notch3 by removing tetracycline treatment (data not shown). Organelle markers, GRP78/BiP and calnexin (green), were detected using primary antibodies, respectively, and visualized with either an Alexa Fluor 488-labeled secondary antibody or an FITC-labeled secondary antibody (left panels). Notch3 (red) was detected using AbN2 developed with either a Rhodamine Red-labeled secondary antibody or a Cy3-labeled secondary antibody (middle panels). The right panels represent the overlay (merge). Most of the aggregates were colocalized with GRP78/BiP and calnexin. These data shown are from representative experiments using WT-2, p.R133C-63 and p.C185R-64 cell lines for GRP78/BiP and WT-78, p.R133C-38, p.C185R-23 cell lines for calnexin, respectively. Scale bar, 25 mm.
These results were also confirmed in a cell proliferation assay using the WST-1 reagent (Fig. 7B and C) . After 3 days of tetracycline treatment, stable cells expressing wild-type Notch3 were nearly 100% viable compared with the untreated cells, whereas cells expressing the mutant Notch3 exhibited significantly decreased viability at 33.2 and 37.8% for p.R133C and p.C185R, respectively (Fig. 7C) . However, the cells expressing mutant Notch3 proteins reached confluence and did not exhibit any detectable apoptosis or other morphological abnormalities. These results suggest that expression of mutant Notch3 or aggregate accumulation decreases cell proliferation rates.
Inhibition of proteasome function increased cell death in cells expressing mutant Notch3
To determine whether apoptosis induced by impaired proteasome function depends on mutant Notch3, cell lines were treated with the proteasome inhibitor MG132 (3 mM), and cell viability was analyzed using the WST-1 assay. As shown in Figure 8A , the cells expressing mutant Notch3 were markedly sensitive to proteasome inhibition, and cell Densitometric analysis of the autoradiograms was performed to estimate the relative amounts of wild-type Notch3 and mutant Notch3. Wild-type Notch3 rapidly disappeared within 2 days, whereas most of mutant Notch3 were still detectable after 2 days. Results represent means+SD of data from two labeling experiments and are shown as the percentage of the material present at time 0.
ÃÃÃ P , 0.0001 relative to wild-type Notch3.
viability was decreased by about 50% in tetracycline-treated cells compared with untreated cells. In cells expressing wildtype Notch3, there were no apparent differences in viability between tetracycline-treated and untreated cells. The effects of MG132 on cell viability are summarized in Figure 8B . These results strongly implicate that proteasome inhibition resulted in cytotoxicity associated with the accumulation of mutant Notch3.
DISCUSSION
In this study, we have shown that mutant Notch3 is more prone to form aggregates than wild-type Notch3 and that the mutant aggregates are resistant to degradation, leading to their accumulation in the ER at least in stably transfected HEK cells. The prolonged ER retention of mutant aggregates also impairs cell proliferation. A previous study reported that mouse mutant Notch3 gives rise to the increased numbers of intracellular aggregates, although the aggregates were apparently not colocalized with the markers for the ER, Golgi complex or the intermediate compartment (16) . It is plausible that the modified Notch3 clone used in this study comprising chimeric receptors with insertion of the Gal4VP16 domain in the C-terminal region affected the subcellular localization of mutant Notch3. In addition, we showed that cells expressing mutant Notch3 exhibit increased sensitivity to the proteasome inhibitor MG132 resulting in cell death, which indicates that an additional stressor may be induced to disrupt cellular function. These findings suggest that impairment of ER function caused by the retention of mutant Notch3 is involved in the pathogenesis of CADASIL.
Excessive protein loading in the ER such as overexpression of either membrane proteins or secretory proteins usually induces the UPR, which is responsible for transcriptional attenuation of protein synthesis, upregulation of ER chaperones and folding enzymes to increase the capacity of the ER for protein folding and degradation (22 -28) . Mutations also cause aberrant folding and accumulation of the mutant protein in the ER. These unfolded proteins are retrotranslocated across the ER membrane and degraded by the ERAD process to relieve ER stress. However, some misfolded proteins are not degraded efficiently and are retained in the ER (29 -33) ; a process which may be central to the pathogenesis of several diseases associated with ER stress. Our results showed that overexpression of wild-type Notch3 and mutant Notch3 induced the formation of aggregates in the ER, although the clearance rates of these proteins were markedly different. The aggregates of mutant Notch3 were retained in the ER and exhibited half-lives of longer than 6 days, but the aggregates of wild-type Notch3 disappeared with a halflife of less than a day. Thus, mutant Notch3 proteins form abnormal aggregates that appear trapped in the ER and are resistant to removal via the ERAD system. In contrast, the wild-type aggregates seem to be transiently formed and are readily susceptible to refolding and degradation. The biological properties that render mutant proteins prone to slower degradation remain to be identified. Because CADASIL mutations result in a free cysteine residue in the extracellular domain of Notch3, it is possible that aberrant disulfide-linking in mutant Notch3 increases the formation of aggregates and impairs the interaction with ER chaperones and proteases for efficient degradation. Recently, it has been reported that CADASIL-associated mutations significantly enhance Notch3 multimerization mediated by disulfide bonds compared with wild-type Notch3 (34) . The structure of mutant Notch3 aggregates, however, may potentially be distinguished from those of wild-type aggregates by resistance to degradation, because in our experiments, wild-type Notch3 was cleared within 2 days after arresting its expression. Our preliminary experiments also revealed that both wild-type Notch3 and mutant Notch3 can be precipitated by centrifugation of cell lysates at 105 000g for 1 h in the presence of 1% Triton X-100 (Supplementary Material, Fig. S3 ), indicating that Notch3 forms a detergent-insoluble complex with a higher molecular weight. Thus, other proteins associated with the large complexes may account for the prolonged ER retention and slower degradation of mutant Notch3.
The immunoprecipitation studies suggest that calnexin only interacts with mutant Notch3. Calnexin functions as a lectin interacting with monoglucosylated oligosaccharides in folding intermediates of glycoproteins (35) . Recently, it has been reported that calnexin retains misfolded proteins in membranous bodies of the ER and attenuates their degradation by the ERAD pathway (36) , and overexpression of calnexin impedes trafficking of the dopamine receptor (37) . Therefore, the specific interaction of mutant Notch3 with calnexin could account for the ER retention and the slower turnover rate of mutant proteins. On the other hand, CADASIL mutations have been reported to impair glycosylation of the truncated forms of Notch3 by Fringe and may induce aberrant dimerization (38) . The glycosylation defects in mutant Notch3 might Figure 6 . Identification of ER chaperones associated with mutant Notch3 by western blot analysis. Cell lysates were prepared from stable cells expressing either wild-type Notch3 or mutant Notch3 (p.R133C and p.C185R). Cell lysates (200 mg) were subjected to immunoprecipitation using an anti-Notch3 antibody (AbN2) or preimmune rabbit IgG (Pre). Immunoprecipitated complexes were subjected to SDS-PAGE, and western blot analysis was performed using mouse monoclonal antibodies against Notch3 (3A2), GRP78/ BiP, calnexin, ERp72 and PDI. Total lysates (30 mg) were used as a positive control (input). The same membrane was probed simultaneously with Calnexin and ERp72 antibodies. Calnexin co-immunoprecipitated with mutant Notch3 but not with wild-type Notch3. In contrast, GRP78/BiP co-immunoprecipitated with both the wild-type and mutant Notch3, The data shown are from one representative experiment for three stable cell lines (WT-2, p.R133C-38 and p.C185R-63). The experiments were performed twice for each stable cell line with identical results. increase its binding affinity to calnexin compared with wildtype Notch3.
Proteasome function is essential for normal ERAD, and its inhibition causes accumulation of misfolded proteins in the ER and activates apoptotic pathways leading to cell death (39) (40) (41) (42) . Our study demonstrated that treatment with the proteasome inhibitor MG132 promoted cell death in cells expressing mutant Notch3, although cell death in cultures was not directly induced by expression of wild-type and mutant Notch3. These findings suggest that an additive effect caused by proteasome inhibition might induce apoptosis of cells with enhanced protein accumulation in the ER. It is conceivable that cells expressing mutant Notch3 develop increased sensitivity to other stress inducers such as hypoxia, oxidative stress and glucose deprivation (43 -45) , all of which may involve proteasome dysfunction.
Our results suggest that the cytotoxic effects of mutant Notch3 are due to its aggregate-prone property and resistance to degradation. Because all of the present experiments were performed with cultured HEK293 cells, we cannot readily extend our conclusions to in vivo effects of the mutation on VSMCs; however, our findings have important implications for our understanding of CADASIL pathology. First, the formation of GOM may be facilitated by the propensity for aggregation of mutant Notch3 because the extracellular domain of mutant Notch3 is a major component of GOM (8) . As GOM deposits are detected around degenerating VSMCs or in the indentations of these cells, but not within the cells, it is possible that its formation occurs on the cell surface, where mutant Notch3 might act as a seed to recruit other proteins for the formation of large aggregates. It is also plausible that GOM deposits are formed in the ER and released in the extracellular space by the degeneration and disruption of VSMCs. Second, several proteins involved in protein folding and degradation have been recently reported to be upregulated in cultivated CADASIL VSMCs, suggesting that the expression of mutant Notch3 induces the UPR or impairs ERAD (21) . Furthermore, disturbances in the cell surface involving cell adhesion or cell -matrix interactions might be due to impaired synthesis and transport of key membrane proteins caused by the insufficient ERAD of mutant Notch3 (20) .
In summary, our study demonstrated that the intrinsic properties of mutant Notch3, which tend to form aggregates that are resistant to the ERAD system, cause toxic effects on the proliferation of cultured cells. Further studies will be necessary to investigate the formation of mutant Notch3 aggregates in animal models and to assess their cytotoxic effects in VSMCs. Nevertheless, our findings raise the possibility that agents that inhibit the aggregation or enhance clearance of mutant Notch3 will become targets for the effective treatment or alleviation of CADASIL.
MATERIALS AND METHODS
Stable cell lines
HEK293 cells were grown in DMEM containing 10% fetal bovine serum and antibiotics. Human Notch3 cDNA (nucleotide numbers, -60-7375) was isolated from a human fetal brain cDNA library. The influenza hemagglutinin tag sequence was inserted in frame at the 3 0 end of the coding region of the Notch3 cDNA. Two CADASIL mutations (p.R133C and p.C185R) in the EGF repeats were induced using a sitedirected mutagenesis kit (Stratagene). The cDNAs of wildtype Notch3 and two Notch3 mutants were cloned into the XbaI and NheI sites of a pcDNA4/TO vector (Invitrogen) to regulate Notch3 expression using the T-Rex system (Invitrogen). All constructs were co-transfected into HEK293 cells with pcDNA/TR6 (Invitrogen) at a 1:1 ratio using an Effectene kit (Qiagen). After 48 h, cells were selected in the presence of 300 mg/ml Zeocin and 15 mg/ml blasticidin-S (Invitrogen). The expression level of Notch3 was determined by western blot analysis using an anti-Notch3 antibody (AbN2) after treatment with tetracycline (Tet; 2 mg/ml) for 48 h. The stable cell lines were maintained in DMEM containing 10% fetal bovine serum, 200 mg/ml Zeocin and 10 mg/ml blasticidin-S. The C2 clone was the stable cell line transfected with empty vectors.
Preparation of anti-Notch3 antibodies
Two rabbit polyclonal anti-human Notch3 antibodies (AbN2 and AbC2) were raised against glutathione-S-transferase fusion proteins containing amino acid residues 1497-1624 and 2261-2321 from the human Notch3, respectively (19) . Monoclonal antibody 3A2 was raised against a synthetic peptide containing amino acid residues 1524 -1538.
Western blot analysis
Cells were harvested and lysed in solution A containing 1% Triton X-100, 0.1 M Tris -HCl, pH 7.4, 0.15 M NaCl and a protease inhibitor cocktail (Boehringer Mannheim) as previously described (19) . Lysates (30 mg/lane) were separated on a 7-10% SDS gel, and the separated proteins were transferred to a nitrocellulose membrane (Bio-Rad). The membrane was blocked in TBST (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween-20) containing 5% non-fat milk and probed with the primary antibodies namely anti-human Notch3 (AbN2 and AbC2), anti-GAPDH (Sigma) and mouse monoclonal antibodies in a Chaperone Sampler kit (BD Biosciences), including anti-GRP78/BiP, anti-calnexin, anti-ERp72 and anti-PDI (protein disulfide isomerase). Immunoreactive proteins were detected by Western Lightning chemiluminescence reagents (Perkin Elmer). Protein concentrations were determined using the micro-BCA assay (Pierce). 
Immunocytochemistry
Cells were cultured in 35 mm Petri dishes coated with poly-L-lysine and fixed in 4% paraformaldehyde in PBS at 48C for 10 min. After treatment with 0.2% Triton X-100 for 10 min, cells were blocked with PBS containing 3% fetal bovine serum for 30 min and incubated for 1 h with the following primary antibodies at room temperature: a rabbit anti-human Notch3 (AbN2) (1 mg/ml), a goat anti-GRP78/BiP (C-20) antibody (Santa Cruz Biotechnology, diluted 1:100), a mouse anti-calnexin antibody (BD Biosciences, diluted 1:100) and a mouse anti-Golgi 58K protein antibody (Sigma, diluted 1:100). For the negative control, we used normal IgG instead of the primary antibody. Cells were washed three times with PBS and incubated for 1 h with the appropriate secondary antibodies including an Alexa Fluor 488-labeled goat anti-mouse antibody, a Rhodamine Red-labeled goat anti-rabbit antibody (Molecular Probes), an FITC-labeled donkey anti-goat antibody and a Cy3-labeled donkey anti-rabbit antibody (Chemicon) at a 1:1000 dilution in PBS. After three washes in PBS, cells were counterstained with DAPI (4 0 ,6 0 -diamino-2-phenylindole, Molecular Probes) (5 mg/ml, 5 min), washed in PBS and examined under a light microscope (Olympus).
Pulse-chase analysis
) were incubated for 24 h in 6-well plates coated with poly-L-lysine and treated with 2 mg/ml tetracycline for 24 h. The cells were then starved for 3 h in cysteine/methionine-free DMEM (Invitrogen) supplemented with 1% L-glutamine and 10% dialyzed fetal bovine serum and labeled for 2 h by the addition of 0.1 mCi/ml Pro-Mix L-[ 35 S] in vitro labeling mix (GE Healthcare). The culture medium was changed to fresh medium containing cold cysteine and methionine and chased for the indicated times. At each time point, cells were harvested and lysed in solution A (described above). The cell lysates were immunoprecipitated with anti-Notch3 (AbN2), and immunocomplexes were subjected to SDS polyacrylamide gel electrophoresis as described above. The separated proteins were visualized by fluorography using the Amplify Fluorographic Reagent (GE Healthcare) and X-ray film (GE Healthcare).
Immunoprecipitation
Cells were harvested and lysed in solution A. The lysates (200 mg of protein) were precleared with a protein G-agarose bead slurry (Boehringer Mannheim) for 1 h at 48C and incubated at 48C for 24 h with 3 ml of AbN2 antibodies (1 mg/ml). Immunocomplexes were pulled down with protein G-agarose beads and washed three times with RIPA buffer (1% Triton X-100, 20 mM Tris-HCl, pH 7.5, 1% deoxycholate, 0.2% SDS, 0.15 M NaCl and a protease inhibitor cocktail). After addition of the gel loading solution with 10% b-mercaptoethanol and boiling for 3 min, samples were loaded on a 7% SDS -PAGE gel. Proteins were transferred to membranes and blotted with Notch3 and several chaperone proteins antibodies as described above. The immunoreactive proteins were detected by chemiluminescence as described above.
Comparison of cell proliferation rate
Stable cells (2 Â 10 4 ) were seeded in the 24-well plates and treated with or without 2 mg/ml tetracycline for the indicated times at 0 (before treatment), 1, 3, 5 days (after treatment). To determine the numbers of proliferating cells at each time point and under each condition (with or without Tet), we separately harvested cells from three wells. Then, cells in each well were stained with Trypan Blue and counted four times. Data were obtained from three independent experiments, and a plot was expressed as the mean values + SD (n ¼ 3, from three wells).
Measurement of cell viability and induction of ER stress
Stable cells (5 Â 10 5 ) were seeded in 6-well plates. After 24 h, cells were incubated in fresh medium containing 2 mg/ml tetracycline for 24 h and then harvested for western blot analysis. To assess cell growth rates, stable cells (2 Â 10 4 ) were seeded in 24-well plates and treated with or without 2 mg/ml tetracycline for the indicated times. Cell growth was determined by two methods: by counting in Trypan Blue solution and by means of a cell proliferation assay using the WST-1 reagent (Cell proliferation assay kit, Chemicon). This kit was used for rapid and sensitive quantification of cell proliferation and viability. The assay is based on the cleavage of the tetrazolium salt WST-1 to formazan by cellular mitochondrial dehydrogenases. To assess the effect of the proteasome inhibitor MG132 (Calbiochem), cells (2 Â 10 4 ) were seeded in 24-well plates coated with poly-L-lysine. After 24 h, cells were treated with MG132 (3 mM) for 24 h in the presence or absence of tetracycline, and cell viability was determined using the WST-1 reagent.
Statistical analysis
Data are presented as means+SD. Statistical analysis was performed using unpaired t-test (two-tailed) or one-way ANOVA with Dunnett's multiple comparison post hoc test (PRISM version 5.0a; GraphPad Software, La Jolla, CA, USA). Values of P , 0.05 were considered significant.
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